That looks to be the case.
The 120 mc patients now also look to be "placebo" patients as well, unfortunately for them. However it more clearly shows the difference between the controls and the 40 and 80 mc groups.
Once the initial excitement wears off about the positive result, they need to do some really hard thinking about how to proceed and ways it could be even improved.
Ann: NTCELL Parkinsons trial patient data at 18 months, page-9
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.49M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $5.169K | 715.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 8014267 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1382834 | 9 |
View Market Depth
| Last trade - 12.28pm 06/09/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |